Literature DB >> 25428678

Impact of insulin like growth factor-1 in development of coronary artery ectasia.

Ibrahim Faruk Akturk1, Ismail Biyik, Ahmet Arif Yalcin, Nilgun Isiksacan, Omer Celik, Derya Ozturk, Mehmet Erturk.   

Abstract

Coronary artery ectasia (CAE) is characterized by inappropriate dilatation of the coronary vasculature. The mechanisms of CAE are not well known. Insulin-like growth factor-1 (IGF-1) may make endothelial cells and smooth muscle cells more sensitive to the effects of growth hormone. In the present study, we hypothesized that IGF-1 may have an impact on the formation of ectasia and aneurysm in arterial system, and aimed to investigate the associations between the presence of CAE and serum IGF-1 levels in patients undergoing coronary angiography. The study included 2.980 subjects undergoing elective diagnostic coronary angiography. We selected 40 patients diagnosed with CAE as CAE group and 44 subjects with absolutely normal coronary arteries were assigned as normal control group. IGF-1 levels were measured in both groups of patients. Groups were similar in terms of age, sex and coronary artery disease risk factors. The serum IGF-1 levels were significantly higher in CAE patients with 109.64 ± 54.64 ng/mL than in controls with 84.76 ± 34.01 ng/mL (p=0.016). HDL levels were lower in ectasia group with 41.5 ± 10.7 mg/dL than controls with 47.7 ± 10.4 mg/dL (p=0.018). By means of logistic regression analysis, high IGF-1 and low HDL levels were found to be independent risk factors for the presence of CAE (p<0.02, p<0.016, respectively). The study revealed that there was a positive correlation between serum IGF-1 levels and presence of CAE, and high IGF-1 levels and low HDL levels were independent risk factors for the presence of CAE. Future studies are needed to confirm these results.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25428678      PMCID: PMC4333962          DOI: 10.17305/bjbms.2014.4.35

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  43 in total

1.  A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction.

Authors:  N Vaessen; P Heutink; J A Janssen; J C Witteman; L Testers; A Hofman; S W Lamberts; B A Oostra; H A Pols; C M van Duijn
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

2.  Origins of coronary artery ectasia.

Authors:  V L Sorrell; M J Davis; A A Bove
Journal:  Lancet       Date:  1996-01-20       Impact factor: 79.321

Review 3.  Aging, atherosclerosis, and IGF-1.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Asif Anwar; Shaw-Yung Shai; Patrice Delafontaine
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-05       Impact factor: 6.053

4.  Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm.

Authors:  P Ramos-Mozo; C Rodriguez; C Pastor-Vargas; L M Blanco-Colio; J Martinez-Gonzalez; O Meilhac; J-B Michel; M Vega de Ceniga; J Egido; J L Martin-Ventura
Journal:  Atherosclerosis       Date:  2012-01-25       Impact factor: 5.162

5.  Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.

Authors:  Montserrat C Cruzado; Norma R Risler; Roberto M Miatello; Guoying Yao; Ernesto L Schiffrin; Rhian M Touyz
Journal:  Am J Hypertens       Date:  2005-01       Impact factor: 2.689

6.  Coronary artery ectasia is related to coronary slow flow and inflammatory activation.

Authors:  Natale Daniele Brunetti; Giuseppe Salvemini; Andrea Cuculo; Antonio Ruggiero; Luisa De Gennaro; Antonio Gaglione; Matteo Di Biase
Journal:  Atherosclerosis       Date:  2014-01-28       Impact factor: 5.162

7.  IGF-1 regulates migration and angiogenesis of human endothelial cells.

Authors:  S Shigematsu; K Yamauchi; K Nakajima; S Iijima; T Aizawa; K Hashizume
Journal:  Endocr J       Date:  1999-03       Impact factor: 2.349

8.  IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population.

Authors:  Mikkel Andreassen; Ilan Raymond; Caroline Kistorp; Per Hildebrandt; Jens Faber; Lars Østergaard Kristensen
Journal:  Eur J Endocrinol       Date:  2008-10-17       Impact factor: 6.664

9.  Insulin-like growth factor 1 opposes the effects of C-reactive protein on endothelial cell activation.

Authors:  Shao-Jun Liu; Yun Zhong; Xiang-Yu You; Wei-Hua Liu; Ai-Qun Li; Shi-Ming Liu
Journal:  Mol Cell Biochem       Date:  2013-09-25       Impact factor: 3.396

10.  Are elevated levels of IGF-1 caused by coronary arteriesoclerosis?: Molecular and clinical analysis.

Authors:  Pawel Burchardt; Anna Gozdzicka-Jozefiak; Jakub Zurawski; Witold Nowak; Julia Durzynska; Rafał Link; Tomasz Grotowski; Tomasz Siminiak
Journal:  Protein J       Date:  2010-11       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.